HomeCompareBSEFF vs MRK

BSEFF vs MRK: Dividend Comparison 2026

BSEFF yields 2.37% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.5K in total portfolio value
10 years
BSEFF
BSEFF
● Live price
2.37%
Share price
$20.25
Annual div
$0.48
5Y div CAGR
-17.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$38.13
Full BSEFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — BSEFF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSEFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSEFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSEFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSEFF
Annual income on $10K today (after 15% tax)
$201.48/yr
After 10yr DRIP, annual income (after tax)
$32.41/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,564.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSEFF + MRK for your $10,000?

BSEFF: 50%MRK: 50%
100% MRK50/50100% BSEFF
Portfolio after 10yr
$39.5K
Annual income
$5,075.96/yr
Blended yield
12.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BSEFF
No analyst data
Altman Z
2.0
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSEFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSEFFMRK
Forward yield2.37%2.81%
Annual dividend / share$0.48$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-17.3%32.7%
Portfolio after 10y$21.2K$57.7K
Annual income after 10y$38.13$10,113.78
Total dividends collected$999.00$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BSEFF vs MRK ($10,000, DRIP)

YearBSEFF PortfolioBSEFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,896$196.03$11,213$373.04$317.00MRK
2$11,824$165.09$12,667$512.06$843.00MRK
3$12,790$138.46$14,439$708.14$1.6KMRK
4$13,801$115.76$16,640$988.16$2.8KMRK
5$14,864$96.54$19,432$1,394.07$4.6KMRK
6$15,984$80.36$23,057$1,992.90$7.1KMRK
7$17,170$66.80$27,889$2,894.79$10.7KMRK
8$18,428$55.46$34,518$4,286.29$16.1KMRK
9$19,763$46.00$43,912$6,494.35$24.1KMRK
10$21,185$38.13$57,714$10,113.78$36.5KMRK

BSEFF vs MRK: Complete Analysis 2026

BSEFFStock

Benesse Holdings, Inc. provides educational, and nursing care and childcare services in Japan and internationally. The company operates through three segments: Education Business in Japan; Nursing Care and Childcare Business; and Kids & Family Business. The company engages in the correspondence course business, school and teacher support business, cram and prep school business, English language lessons for children business, and other businesses for preschool to high school students; and nursing care and childcare business, which include the operation of nursing homes for seniors comprising fee-based homes and elderly houses with care services, home help and daytime nursing care services, food delivery, and daycare and afterschool care services. It also offers interpretation and translation services; information and products relating to pregnancy, childbirth, and parenting; lifestyle information and support everyday living through forums for communication with customers; and magazines, websites, and others to help enrich life with pets. The company was formerly known as Benesse Corporation and changed its name to Benesse Holdings, Inc. in 2009. Benesse Holdings, Inc. was incorporated in 1955 and is headquartered in Okayama, Japan.

Full BSEFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BSEFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSEFF vs SCHDBSEFF vs JEPIBSEFF vs OBSEFF vs KOBSEFF vs MAINBSEFF vs JNJBSEFF vs ABBVBSEFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.